{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,22]],"date-time":"2026-09-22T12:11:06Z","timestamp":1790079066219,"version":"4.0.1"},"reference-count":46,"publisher":"MDPI AG","issue":"18","license":[{"start":{"date-parts":[[2026,9,21]],"date-time":"2026-09-21T00:00:00Z","timestamp":1789948800000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["J. Clin. Med.","JCM"],"abstract":"<jats:p>Objective: To determine the incidence of recurrent ischemic stroke following percutaneous left atrial appendage closure in patients with previous thromboembolic events despite oral anticoagulation. Methods: We conducted a systematic review and meta-analysis of studies of any design reporting ischemic stroke recurrence after left atrial appendage closure in patients with prior ischemic stroke despite oral anticoagulation therapy. The literature search was conducted in MEDLINE, Embase, and the Cochrane Library for studies published between 1 January 2010 and 31 December 2025. Data on study design, population characteristics, indexed intervention, and outcomes were extracted from each included report. The primary outcome was ischemic stroke occurring after left atrial appendage closure, as defined by each individual study. A pooled incidence rate was estimated using a random-effects model to account for anticipated between-study heterogeneity. The study is registered in Open Science Framework. The Risk of Bias in Non-randomized Studies of Interventions assessment tool was used to assess the risk of bias. Results: Overall, eight studies of a total of 1091 patients met the eligibility criteria. Patients were elderly (mean age range 71.8 to 78.1 years), 33% to 53% were women, and thromboembolic risk was consistently high (mean CHA2DS2-VASc scores \u2265 5.0). The risk of bias across the included studies was either moderate or serious. Antithrombotic therapy after left atrial appendage closure varied considerably across the included studies. In one study, all patients were discharged on dual antiplatelet therapy, whereas in five studies &gt;70% received oral anticoagulation alone or in combination with antiplatelet therapy at discharge. In six studies, antithrombotic therapy at follow-up was reported, with the proportion of patients on oral anticoagulation alone or in combination with antiplatelet therapy at follow-up ranging from 8.1% to 100% in individual studies. Follow-up duration ranged from 1.0 to 3.1 years. At a mean follow-up of 17.7 months the pooled incidence of the ischemic stroke recurrence rate following left atrial appendage closure was 3.1% per year (95% confidence interval 2.35\u20134.20%). Conclusions: Among elderly patients with prior ischemic stroke despite oral anticoagulation, the recurrence rate of ischemic stroke following left atrial appendage closure was 3.1% per year. Given the residual risk of stroke recurrence and the substantial heterogeneity in post-procedural antithrombotic management observed across studies, prospective randomized trials are urgently needed to define both the protective impact of left atrial appendage closure and the optimal antithrombotic strategy in this high-risk population.<\/jats:p>","DOI":"10.3390\/jcm15187320","type":"journal-article","created":{"date-parts":[[2026,9,22]],"date-time":"2026-09-22T11:09:35Z","timestamp":1790075375000},"page":"7320","update-policy":"https:\/\/doi.org\/10.3390\/mdpi_crossmark_policy","source":"Crossref","is-referenced-by-count":0,"title":["Recurrent Stroke Following Left Atrial Appendage Closure in Patients with Breakthrough Stroke: A Systematic Review and Meta-Analysis"],"prefix":"10.3390","volume":"15","author":[{"ORCID":"https:\/\/orcid.org\/0000-0001-6756-3295","authenticated-orcid":false,"given":"Tommaso","family":"Bini","sequence":"first","affiliation":[{"name":"Department of Cardiology, Inselspital, Bern University Hospital, University of Bern, 3010 Bern, Switzerland"},{"name":"Graduate School for Health Sciences, University of Bern, 3012 Bern, Switzerland"}],"role":[{"vocabulary":"crossref","role":"author"},{"role":"conceptualization","vocabulary":"credit"},{"role":"investigation","vocabulary":"credit"},{"role":"visualization","vocabulary":"credit"},{"role":"methodology","vocabulary":"credit"},{"role":"resources","vocabulary":"credit"},{"role":"data-curation","vocabulary":"credit"},{"role":"writing-original-draft","vocabulary":"credit"},{"role":"writing-review-editing","vocabulary":"credit"},{"role":"formal-analysis","vocabulary":"credit"}]},{"given":"Marco","family":"Gamardella","sequence":"additional","affiliation":[{"name":"Department of Cardiology, Inselspital, Bern University Hospital, University of Bern, 3010 Bern, Switzerland"}],"role":[{"vocabulary":"crossref","role":"author"},{"role":"data-curation","vocabulary":"credit"},{"role":"investigation","vocabulary":"credit"},{"role":"writing-review-editing","vocabulary":"credit"}]},{"ORCID":"https:\/\/orcid.org\/0009-0005-1018-5162","authenticated-orcid":false,"given":"Antanas","family":"Gasys","sequence":"additional","affiliation":[{"name":"Department of Cardiology, Inselspital, Bern University Hospital, University of Bern, 3010 Bern, Switzerland"},{"name":"Graduate School for Health Sciences, University of Bern, 3012 Bern, Switzerland"}],"role":[{"vocabulary":"crossref","role":"author"},{"role":"data-curation","vocabulary":"credit"},{"role":"writing-review-editing","vocabulary":"credit"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-2492-9960","authenticated-orcid":false,"given":"Roberto","family":"Galea","sequence":"additional","affiliation":[{"name":"Department of Cardiology, Inselspital, Bern University Hospital, University of Bern, 3010 Bern, Switzerland"},{"name":"Department of Cardiology, Hospital Centre of Biel, 2502 Biel, Switzerland"}],"role":[{"vocabulary":"crossref","role":"author"},{"role":"writing-review-editing","vocabulary":"credit"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-0827-1329","authenticated-orcid":false,"given":"Laurent","family":"Roten","sequence":"additional","affiliation":[{"name":"Department of Cardiology, Inselspital, Bern University Hospital, University of Bern, 3010 Bern, Switzerland"}],"role":[{"vocabulary":"crossref","role":"author"},{"role":"writing-review-editing","vocabulary":"credit"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-3890-3849","authenticated-orcid":false,"given":"David","family":"Seiffge","sequence":"additional","affiliation":[{"name":"Department of Neurology, Inselspital, Bern University Hospital, University of Bern, 3010 Bern, Switzerland"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Lorenz","family":"R\u00e4ber","sequence":"additional","affiliation":[{"name":"Department of Cardiology, Inselspital, Bern University Hospital, University of Bern, 3010 Bern, Switzerland"}],"role":[{"vocabulary":"crossref","role":"author"},{"role":"writing-review-editing","vocabulary":"credit"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-2128-9205","authenticated-orcid":false,"given":"George CM","family":"Siontis","sequence":"additional","affiliation":[{"name":"Department of Cardiology, Inselspital, Bern University Hospital, University of Bern, 3010 Bern, Switzerland"},{"name":"Institute of Social and Preventive Medicine (ISPM), University of Bern, 3012 Bern, Switzerland"}],"role":[{"vocabulary":"crossref","role":"author"},{"role":"investigation","vocabulary":"credit"},{"role":"conceptualization","vocabulary":"credit"},{"role":"visualization","vocabulary":"credit"},{"role":"methodology","vocabulary":"credit"},{"role":"writing-review-editing","vocabulary":"credit"},{"role":"data-curation","vocabulary":"credit"},{"role":"validation","vocabulary":"credit"},{"role":"supervision","vocabulary":"credit"}]}],"member":"1968","published-online":{"date-parts":[[2026,9,21]]},"reference":[{"key":"ref_1","doi-asserted-by":"crossref","first-page":"154","DOI":"10.1016\/S0140-6736(14)61774-8","article-title":"50 year trends in atrial fibrillation prevalence, incidence, risk factors, and mortality in the Framingham Heart Study: A cohort study","volume":"386","author":"Schnabel","year":"2015","journal-title":"Lancet"},{"key":"ref_2","doi-asserted-by":"crossref","first-page":"3314","DOI":"10.1093\/eurheartj\/ehae176","article-title":"2024 ESC Guidelines for the management of atrial fibrillation developed in collaboration with the European Association for Cardio-Thoracic Surgery (EACTS)","volume":"45","author":"Rienstra","year":"2024","journal-title":"Eur. Heart J."},{"key":"ref_3","doi-asserted-by":"crossref","first-page":"e1","DOI":"10.1161\/CIR.0000000000001193","article-title":"2023 ACC\/AHA\/ACCP\/HRS Guideline for the Diagnosis and Management of Atrial Fibrillation: A Report of the American College of Cardiology\/American Heart Association Joint Committee on Clinical Practice Guidelines","volume":"149","author":"Joglar","year":"2024","journal-title":"Circulation"},{"key":"ref_4","doi-asserted-by":"crossref","first-page":"1139","DOI":"10.1056\/NEJMoa0905561","article-title":"Dabigatran versus warfarin in patients with atrial fibrillation","volume":"361","author":"Connolly","year":"2009","journal-title":"N. Engl. J. Med."},{"key":"ref_5","doi-asserted-by":"crossref","first-page":"2093","DOI":"10.1056\/NEJMoa1310907","article-title":"Edoxaban versus warfarin in patients with atrial fibrillation","volume":"369","author":"Giugliano","year":"2013","journal-title":"N. Engl. J. Med."},{"key":"ref_6","doi-asserted-by":"crossref","first-page":"981","DOI":"10.1056\/NEJMoa1107039","article-title":"Apixaban versus warfarin in patients with atrial fibrillation","volume":"365","author":"Granger","year":"2011","journal-title":"N. Engl. J. Med."},{"key":"ref_7","doi-asserted-by":"crossref","first-page":"883","DOI":"10.1056\/NEJMoa1009638","article-title":"Rivaroxaban versus warfarin in nonvalvular atrial fibrillation","volume":"365","author":"Patel","year":"2011","journal-title":"N. Engl. J. Med."},{"key":"ref_8","doi-asserted-by":"crossref","first-page":"955","DOI":"10.1016\/S0140-6736(13)62343-0","article-title":"Comparison of the efficacy and safety of new oral anticoagulants with warfarin in patients with atrial fibrillation: A meta-analysis of randomised trials","volume":"383","author":"Ruff","year":"2014","journal-title":"Lancet"},{"key":"ref_9","doi-asserted-by":"crossref","unstructured":"Galea, R., Seiffge, D., and Raber, L. (2023). Atrial Fibrillation and Ischemic Stroke despite Oral Anticoagulation. J. Clin. Med., 12.","DOI":"10.3390\/jcm12185784"},{"key":"ref_10","doi-asserted-by":"crossref","unstructured":"RAF and RENO-EXTEND Investigators (2023). Risk of recurrent stroke in patients with atrial fibrillation treated with oral anticoagulants alone or in combination with anti-platelet therapy. Eur. Stroke J., 8, 722\u2013730.","DOI":"10.1177\/23969873231183211"},{"key":"ref_11","doi-asserted-by":"crossref","first-page":"2620","DOI":"10.1161\/STROKEAHA.121.038239","article-title":"Recurrent Ischemic Stroke and Bleeding in Patients with Atrial Fibrillation Who Suffered an Acute Stroke While on Treatment with Nonvitamin K Antagonist Oral Anticoagulants: The RENO-EXTEND Study","volume":"53","author":"Paciaroni","year":"2022","journal-title":"Stroke"},{"key":"ref_12","doi-asserted-by":"crossref","first-page":"588","DOI":"10.1136\/jnnp-2021-328391","article-title":"Aetiology, secondary prevention strategies and outcomes of ischaemic stroke despite oral anticoagulant therapy in patients with atrial fibrillation","volume":"93","author":"Polymeris","year":"2022","journal-title":"J. Neurol. Neurosurg. Psychiatry"},{"key":"ref_13","doi-asserted-by":"crossref","first-page":"677","DOI":"10.1002\/ana.25700","article-title":"Ischemic Stroke despite Oral Anticoagulant Therapy in Patients with Atrial Fibrillation","volume":"87","author":"Seiffge","year":"2020","journal-title":"Ann. Neurol."},{"key":"ref_14","doi-asserted-by":"crossref","first-page":"1150","DOI":"10.1161\/STROKEAHA.119.027275","article-title":"Atrial Fibrillation-Associated Ischemic Stroke Patients with Prior Anticoagulation Have Higher Risk for Recurrent Stroke","volume":"51","author":"Tanaka","year":"2020","journal-title":"Stroke"},{"key":"ref_15","doi-asserted-by":"crossref","first-page":"1062","DOI":"10.1136\/jnnp-2021-326166","article-title":"Ischaemic stroke on anticoagulation therapy and early recurrence in acute cardioembolic stroke: The IAC study","volume":"92","author":"Yaghi","year":"2021","journal-title":"J. Neurol. Neurosurg. Psychiatry"},{"key":"ref_16","doi-asserted-by":"crossref","first-page":"1807","DOI":"10.1093\/eurheartj\/ehad200","article-title":"Outcomes of patients with atrial fibrillation and ischemic stroke while on oral anticoagulation","volume":"44","author":"Benz","year":"2023","journal-title":"Eur. Heart J."},{"key":"ref_17","doi-asserted-by":"crossref","first-page":"2081","DOI":"10.1056\/NEJMoa2101897","article-title":"Left Atrial Appendage Occlusion during Cardiac Surgery to Prevent Stroke","volume":"384","author":"Whitlock","year":"2021","journal-title":"N. Engl. J. Med."},{"key":"ref_18","doi-asserted-by":"crossref","first-page":"12","DOI":"10.1253\/circj.CJ-25-0678","article-title":"Management Strategies for Patients with Atrial Fibrillation-Related Ischemic Stroke Despite Oral Anticoagulation","volume":"90","author":"Chatani","year":"2025","journal-title":"Circ. J."},{"key":"ref_19","doi-asserted-by":"crossref","first-page":"475","DOI":"10.1016\/j.hrthm.2024.10.061","article-title":"Management strategies to prevent stroke in patients with atrial fibrillation and malignant left atrial appendage","volume":"22","author":"Chatani","year":"2025","journal-title":"Heart Rhythm"},{"key":"ref_20","doi-asserted-by":"crossref","first-page":"1854","DOI":"10.1016\/j.jcin.2024.07.002","article-title":"Reply: Left Atrial Appendage Occlusion in Patients with Anticoagulation Failure (?) vs Anticoagulation Contraindication (!)?","volume":"17","author":"Aarnink","year":"2024","journal-title":"JACC Cardiovasc. Interv."},{"key":"ref_21","first-page":"212","article-title":"Left Atrial Appendage Occlusion as Adjunctive Therapy to Anticoagulation for Stroke Recurrence","volume":"31","author":"Freixa","year":"2019","journal-title":"J. Invasive Cardiol."},{"key":"ref_22","doi-asserted-by":"crossref","first-page":"n71","DOI":"10.1136\/bmj.n71","article-title":"The PRISMA 2020 statement: An updated guideline for reporting systematic reviews","volume":"372","author":"Page","year":"2021","journal-title":"BMJ"},{"key":"ref_23","doi-asserted-by":"crossref","first-page":"i4919","DOI":"10.1136\/bmj.i4919","article-title":"ROBINS-I: A tool for assessing risk of bias in non-randomised studies of interventions","volume":"355","author":"Sterne","year":"2016","journal-title":"BMJ"},{"key":"ref_24","doi-asserted-by":"crossref","unstructured":"Rover, C., Knapp, G., and Friede, T. (2015). Hartung-Knapp-Sidik-Jonkman approach and its modification for random-effects meta-analysis with few studies. BMC Med. Res. Methodol., 15.","DOI":"10.1186\/s12874-015-0091-1"},{"key":"ref_25","doi-asserted-by":"crossref","first-page":"139","DOI":"10.1016\/j.cct.2015.09.002","article-title":"Meta-analysis in clinical trials revisited","volume":"45","author":"DerSimonian","year":"2015","journal-title":"Contemp. Clin. Trials"},{"key":"ref_26","doi-asserted-by":"crossref","first-page":"1539","DOI":"10.1002\/sim.1186","article-title":"Quantifying heterogeneity in a meta-analysis","volume":"21","author":"Higgins","year":"2002","journal-title":"Stat. Med."},{"key":"ref_27","doi-asserted-by":"crossref","first-page":"227","DOI":"10.23736\/S0031-0808.21.04446-3","article-title":"Left atrial appendage closure: A new strategy for cardioembolic events despite oral anticoagulation","volume":"65","author":"Falasconi","year":"2023","journal-title":"Panminerva Med."},{"key":"ref_28","doi-asserted-by":"crossref","first-page":"395","DOI":"10.1002\/joa3.12838","article-title":"Left atrial appendage occlusion after thromboembolic events or left atrial appendage sludge during anticoagulation therapy: Is two better than one? Real-world experience from a tertiary care hospital","volume":"39","author":"Margonato","year":"2023","journal-title":"J. Arrhythmia"},{"key":"ref_29","doi-asserted-by":"crossref","first-page":"132875","DOI":"10.1016\/j.ijcard.2024.132875","article-title":"Left atrial appendage closure in patients with failure of anticoagulation therapy: A multicenter comparative study on the hybrid strategy using DOACs and VKAs","volume":"421","author":"Preda","year":"2025","journal-title":"Int. J. Cardiol."},{"key":"ref_30","doi-asserted-by":"crossref","first-page":"816","DOI":"10.1111\/ene.13894","article-title":"Oral anticoagulation and left atrial appendage closure: A new strategy for recurrent cardioembolic stroke","volume":"26","author":"Masjuan","year":"2019","journal-title":"Eur. J. Neurol."},{"key":"ref_31","doi-asserted-by":"crossref","first-page":"255","DOI":"10.1080\/17843286.2020.1821494","article-title":"Left atrial appendage occlusion in recurrent ischaemic stroke, a multicentre experience","volume":"77","author":"Galloo","year":"2022","journal-title":"Acta Clin. Belg."},{"key":"ref_32","first-page":"28","article-title":"Left atrial appendage occlusion for stroke despite oral anticoagulation (resistant stroke). Results from the Amplatzer Cardiac Plug registry","volume":"73","author":"Freixa","year":"2020","journal-title":"Rev. Esp. Cardiol. (Engl. Ed.)"},{"key":"ref_33","doi-asserted-by":"crossref","first-page":"17","DOI":"10.1016\/j.ijcard.2022.02.030","article-title":"Residual stroke risk after left atrial appendage closure in patients with prior oral anticoagulation failure","volume":"354","author":"Pracon","year":"2022","journal-title":"Int. J. Cardiol."},{"key":"ref_34","doi-asserted-by":"crossref","first-page":"120","DOI":"10.1136\/svn-2024-003143","article-title":"Left atrial appendage closure in patients with atrial fibrillation and acute ischaemic stroke despite anticoagulation","volume":"10","author":"Yaghi","year":"2025","journal-title":"Stroke Vasc. Neurol."},{"key":"ref_35","doi-asserted-by":"crossref","first-page":"1150","DOI":"10.1001\/jamaneurol.2024.2882","article-title":"Left Atrial Appendage Occlusion vs Standard of Care After Ischemic Stroke Despite Anticoagulation","volume":"81","author":"Maarse","year":"2024","journal-title":"JAMA Neurol."},{"key":"ref_36","doi-asserted-by":"crossref","first-page":"e70365","DOI":"10.1111\/ene.70365","article-title":"Percutaneous Left Atrial Appendage Closure in Patients with Cardioembolic Breakthrough Stroke: An International Observational Study","volume":"32","author":"Galea","year":"2025","journal-title":"Eur. J. Neurol."},{"key":"ref_37","doi-asserted-by":"crossref","first-page":"2715","DOI":"10.1016\/j.jacep.2025.07.021","article-title":"Left Atrial Appendage Closure for Patients with a History of Ischemic Stroke Despite Oral Anticoagulant","volume":"11","author":"Fukushima","year":"2025","journal-title":"JACC Clin. Electrophysiol."},{"key":"ref_38","doi-asserted-by":"crossref","first-page":"e153","DOI":"10.1161\/CIR.0000000000001052","article-title":"Heart Disease and Stroke Statistics-2022 Update: A Report from the American Heart Association","volume":"145","author":"Tsao","year":"2022","journal-title":"Circulation"},{"key":"ref_39","first-page":"e358","article-title":"Association of Alternative Anticoagulation Strategies and Outcomes in Patients with Ischemic Stroke While Taking a Direct Oral Anticoagulant","volume":"101","author":"Ip","year":"2023","journal-title":"Neurology"},{"key":"ref_40","doi-asserted-by":"crossref","first-page":"805","DOI":"10.1001\/jamaneurol.2024.1892","article-title":"Recurrent Ischemic Stroke in Patients with Atrial Fibrillation While Receiving Oral Anticoagulants","volume":"81","author":"Hindsholm","year":"2024","journal-title":"JAMA Neurol."},{"key":"ref_41","doi-asserted-by":"crossref","first-page":"e032454","DOI":"10.1161\/JAHA.123.032454","article-title":"Changing or Retaining Direct Oral Anticoagulant After Ischemic Stroke Despite Direct Oral Anticoagulant Treatment","volume":"13","author":"Lin","year":"2024","journal-title":"J. Am. Heart Assoc."},{"key":"ref_42","doi-asserted-by":"crossref","first-page":"263","DOI":"10.1378\/chest.09-1584","article-title":"Refining clinical risk stratification for predicting stroke and thromboembolism in atrial fibrillation using a novel risk factor-based approach: The euro heart survey on atrial fibrillation","volume":"137","author":"Lip","year":"2010","journal-title":"Chest"},{"key":"ref_43","doi-asserted-by":"crossref","first-page":"1500","DOI":"10.1093\/eurheartj\/ehr488","article-title":"Evaluation of risk stratification schemes for ischaemic stroke and bleeding in 182 678 patients with atrial fibrillation: The Swedish Atrial Fibrillation cohort study","volume":"33","author":"Friberg","year":"2012","journal-title":"Eur. Heart J."},{"key":"ref_44","unstructured":"National Collaborating Centre for Chronic Conditions (Great Britain) (2006). Atrial Fibrillation: National Clinical Guideline for Management in Primary and Secondary Care, Royal College of Physicians."},{"key":"ref_45","doi-asserted-by":"crossref","first-page":"696","DOI":"10.1001\/jamaneurol.2025.1337","article-title":"Residual Risk of Recurrent Stroke Despite Anticoagulation in Patients with Atrial Fibrillation: A Systematic Review and Meta-Analysis","volume":"82","author":"McCabe","year":"2025","journal-title":"JAMA Neurol."},{"key":"ref_46","first-page":"140","article-title":"Left atrial appendage occlusion plus oral anticoagulation in stroke patients despite ongoing anticoagulation: Rationale and design of the ADD-LAAO clinical trial","volume":"7","author":"Amaro","year":"2025","journal-title":"REC Interv. Cardiol."}],"container-title":["Journal of Clinical Medicine"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.mdpi.com\/2077-0383\/15\/18\/7320\/pdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,9,22]],"date-time":"2026-09-22T11:35:12Z","timestamp":1790076912000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.mdpi.com\/2077-0383\/15\/18\/7320"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,9,21]]},"references-count":46,"journal-issue":{"issue":"18","published-online":{"date-parts":[[2026,9]]}},"alternative-id":["jcm15187320"],"URL":"https:\/\/doi.org\/10.3390\/jcm15187320","relation":{},"ISSN":["2077-0383"],"issn-type":[{"value":"2077-0383","type":"electronic"}],"subject":[],"published":{"date-parts":[[2026,9,21]]}}}